|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Heist RS and Engelman JA: SnapShot:
Non-small cell lung cancer. Cancer Cell. 21(448.e2)2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Wen J, Hu Y, Liu Q, Ling Y, Zhang S, Luo
K, Xie X, Fu J and Yang H: miR-424 coordinates multilayered
regulation of cell cycle progression to promote esophageal squamous
cell carcinoma cell proliferation. EBioMedicine. 37:110–124.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhou YW, Zhang H, Duan CJ, Gao Y, Cheng
YD, He D, Li R and Zhang CF: miR-675-5p enhances tumorigenesis and
metastasis of esophageal squamous cell carcinoma by targeting
REPS2. Oncotarget. 7:30730–30747. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chang RM, Xiao S, Lei X, Yang H, Fang F
and Yang LY: miRNA-487a promotes proliferation and metastasis in
hepatocellular carcinoma. Clin Cancer Res. 23:2593–2604.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Song H, Li D, Wu T, Xie D, Hua K, Hu J,
Deng X, Ji C, Deng Y and Fang L: MicroRNA-301b promotes cell
proliferation and apoptosis resistance in triple-negative breast
cancer by targeting CYLD. BMB Rep. 51:602–607. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jiang LH, Zhang HD and Tang JH: MiR-30a: A
novel biomarker and potential therapeutic target for cancer. J
Oncol. 2018(5167829)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
He D, Wang J, Zhang C, Shan B, Deng X, Li
B, Zhou Y, Chen W, Hong J, Gao Y, et al: Down-regulation of
miR-675-5p contributes to tumor progression and development by
targeting pro-tumorigenic GPR55 in non-small cell lung cancer. Mol
Cancer. 14(73)2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen W, Wang J, Liu S, Wang S, Cheng Y,
Zhou W, Duan C and Zhang C: MicroRNA-361-3p suppresses tumor cell
proliferation and metastasis by directly targeting SH2B1 in NSCLC.
J Exp Clin Cancer Res. 35(76)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Iqbal MA, Arora S, Prakasam G, Calin GA
and Syed MA: MicroRNA in lung cancer: Role, mechanisms, pathways
and therapeutic relevance. Mol Aspects Med. 70:3–20.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jang SG, Yoo CW, Park SY, Kang S and Kim
HK: Low expression of miR-449 in gynecologic clear cell carcinoma.
Int J Gynecol Cancer. 24:1558–1563. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Buurman R, Gürlevik E, Schäffer V, Eilers
M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F and
Skawran B: Histone deacetylases activate hepatocyte growth factor
signaling by repressing microRNA-449 in hepatocellular carcinoma
cells. Gastroenterology. 143:811–820.e15. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li Z, Huang X, Xu J, Su Q, Zhao J and Ma
J: miR-449 overexpression inhibits papillary thyroid carcinoma cell
growth by targeting RET kinase-β-catenin signaling pathway. Int J
Oncol. 49:1629–1637. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jiang J, Yang X, He X, Ma W, Wang J, Zhou
Q, Li M and Yu S: MicroRNA-449b-5p suppresses the growth and
invasion of breast cancer cells via inhibiting CREPT-mediated
Wnt/β-catenin signaling. Chem Biol Interact. 302:74–82.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expres- sion data using real-time quantitative PCR
and the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Legras A, Pécuchet N, Imbeaud S, Pallier
K, Didelot A, Roussel H, Gibault L, Fabre E, Le Pimpec-Barthes F,
Laurent-Puig P and Blons H: Epithelial-to-mesenchymal transition
and MicroRNAs in lung cancer. Cancers (Basel). 9(pii:
E101)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–44.
2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Heinrich PC, Behrmann I, Haan S, Hermanns
HM, Müller-Newen G and Schaper F: Principles of interleukin
(IL)-6-type cytokine signalling and its regulation. Biochem J.
374:1–20. 2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Naugler WE and Karin M: The wolf in
sheep's clothing: The role of interleukin-6 in immunity,
inflammation and cancer. Trends Mol Med. 14:109–119.
2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bowman T, Garcia R, Turkson J and Jove R:
STATs in oncogenesis. Oncogene. 19:2474–2488. 2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Marotta LL, Almendro V, Marusyk A,
Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ,
Choudhury SA, Maruyama R, et al: The JAK2/STAT3 signaling pathway
is required for growth of CD44(+) CD24(-) stem cell-like breast
cancer cells in human tumors. J Clin Invest. 121:2723–2735.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Bromberg J and Darnell JE Jr: The role of
STATs in transcriptional control and their impact on cellular
function. Oncogene. 19:2468–2473. 2000.PubMed/NCBI View Article : Google Scholar
|
